David A. Kessler
Corporate Officer/Principal chez The University of California, San Francisco
Profil
David A.
Kessler is the founder of Evergreen Behavioral Solutions, Inc. founded in 2001.
He is currently a Professor at The University of California, San Francisco since 2003.
He was also the Commissioner at US Food & Drug Administration from 1990 to 1997 and the Dean at Yale School of Medicine from 1997 to 2003.
Dr. Kessler's education history includes an undergraduate degree from Amherst College in 1973, a doctorate from Harvard Medical School in 1979, and a graduate degree from The University of Chicago Law School in 1978.
Postes actifs de David A. Kessler
| Sociétés | Poste | Début |
|---|---|---|
| The University of California, San Francisco | Corporate Officer/Principal | 01/01/2003 |
Anciens postes connus de David A. Kessler
| Sociétés | Poste | Fin |
|---|---|---|
| Yale School of Medicine | Corporate Officer/Principal | 01/01/2003 |
US Food & Drug Administration
 US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Corporate Officer/Principal | 01/03/1997 |
| STOKE THERAPEUTICS, INC. | Directeur/Membre du Conseil | - |
| IMMUCOR, INC. | Directeur/Membre du Conseil | - |
Aptalis Holdings, Inc.
 Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Directeur/Membre du Conseil | - |
Formation de David A. Kessler
| Amherst College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
| The University of Chicago Law School | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| STOKE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 8 |
|---|---|
Immucor, Inc.
 Immucor, Inc. Medical SpecialtiesHealth Technology Immucor, Inc. develops, manufactures and sells transfusion and transplantation diagnostics products. It engages in the development, manufacture, and sale of products used by hospital blood banks, clinical laboratories, and blood donor centers to detect and identify certain properties of human blood prior to patient transfusion. The company was founded on May 19,1982 and is headquartered in Norcross, GA. | Health Technology |
Elizabeth Glaser Pediatric AIDS Foundation
 Elizabeth Glaser Pediatric AIDS Foundation Miscellaneous Commercial ServicesCommercial Services Elizabeth Glaser Pediatric AIDS Foundation engages in preventing pediatric Human Immunodeficiency Virus (HIV) and Acquired Immune Deficiency Syndrome (AIDS). The company was founded by Susie Zeegen in 1988 and is headquartered in Washington, DC. | Commercial Services |
TPG Growth LLC
 TPG Growth LLC Investment ManagersFinance TPG Growth LLC is a Venture Capital firm, a subsidiary of TPG Capital Advisors LLC founded in 2000 by William E. McGlashan and Michael Guthrie. The firm is headquartered in San Francisco, United States with additional office in London, United Kingdom. | Finance |
US Food & Drug Administration
US Food & Drug Administration General GovernmentGovernment US Food & Drug Administration operates agencies to protect health and human services. It protects and promotes public health through the control and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs, vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices, cosmetics, animal foods and feed and veterinary products. The company was founded by Theodore Roosevelt and Harvey Washington Wiley on 30th June, 1906 and is headquartered in Silver Spring, MD. | Government |
Tokai Pharmaceuticals, Inc.
 Tokai Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tokai Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in developing novel proprietary therapies for the treatment of prostate cancer and hormonally driven diseases. The company was founded by Joseph A. Yanchik, Gregory L. Verdine, and Seth L. Harrison on March 26, 2004 and is headquartered in Boston, MA. | Health Technology |
Center for Science in the Public Interest
 Center for Science in the Public Interest Miscellaneous Commercial ServicesCommercial Services Center for Science in the Public Interest provides nutrition health, food safety, alcohol policy, and sound science. The company was founded in 1971 by Michael Jacobson and James B. Sullivan and is headquartered in Washington, DC. | Commercial Services |
Aptalis Holdings, Inc.
Aptalis Holdings, Inc. Pharmaceuticals: MajorHealth Technology Aptalis Holdings Inc. operates as a holding company that develops, manufactures, licenses, markets and distributes therapies for unmet medical needs. It includes cystic fibrosis and gastrointestinal disorders through its subsidiaries. It also formulates and clinically develops enhanced pharmaceutical, biopharmaceutical products for itself and others using its proprietary technology platforms including bioavailability enhancement of poorly soluble drugs, custom release profiles, taste-masking and orally disintegration tablet formulations. The company was founded on January 10, 2008 and is headquartered in Bridgewater, NJ. | Health Technology |
Evergreen Behavioral Solutions, Inc.
 Evergreen Behavioral Solutions, Inc. Other Consumer ServicesConsumer Services Vtrim provided behavior-based dieting and weight management programs through online. The firm's services are available to the general public and to university populations. The company was founded in 2001 and was headquartered in Burlington, VT. | Consumer Services |
